Cargando…
Simvastatin reduces the carcinogenic effect of 3-methylcholanthrene in renal epithelial cells through histone deacetylase 1 inhibition and RhoA reactivation
The therapeutic effects of simvastatin for renal cell carcinoma (RCC) are controversial. In this study, the effects of simvastatin on the carcinogenic properties of 3-methylcholanthrene (3MC; an aryl-hydrocarbon receptor [AhR] agonist) in human renal epithelial cells (hRECs) were investigated. We ex...
Autores principales: | Chang, Chih-Cheng, Huang, Kuo-How, Hsu, Sung-Po, Lee, Yuan-Chii G., Sue, Yuh-Mou, Juan, Shu-Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6418087/ https://www.ncbi.nlm.nih.gov/pubmed/30872677 http://dx.doi.org/10.1038/s41598-019-40757-6 |
Ejemplares similares
-
Author Correction: Simvastatin reduces the carcinogenic effect of 3-methylcholanthrene in renal epithelial cells through histone deacetylase 1 inhibition and RhoA reactivation
por: Chang, Chih-Cheng, et al.
Publicado: (2020) -
3-Methylcholanthrene, an AhR Agonist, Caused Cell-Cycle Arrest by Histone Deacetylation through a RhoA-Dependent Recruitment of HDAC1 and pRb2 to E2F1 Complex
por: Chang, Chih-Cheng, et al.
Publicado: (2014) -
Tumoricidal Activity of Simvastatin in Synergy with RhoA Inactivation in Antimigration of Clear Cell Renal Cell Carcinoma Cells
por: Lee, Yuan-Chii Gladys, et al.
Publicado: (2023) -
RhoA/Rho-Kinase and Nitric Oxide in Vascular Reactivity in Rats with Endotoxaemia
por: Liao, Mei-Hui, et al.
Publicado: (2013) -
The Potency of 20-Methylcholanthrene Relative to Other Carcinogens on Bladder Implantation
por: Bonser, G. M., et al.
Publicado: (1963)